Phytotherapeutische Optionen in der Prävention

Zusammenfassung

Die Prävention von häufigen Erkrankungen steht immer mehr im Fokus auch des öffentlichen Interesses. Da Präventionsmaßnahmen nebenwirkungsarm und leicht durchführbar sein müssen, erscheint Phytotherapie dafür besonders geeignet. Präventionsstudien sind jedoch sehr aufwendig und zudem fehleranfällig. Qualitativ hochwertige Studien sind deshalb eher selten, dies gilt aus leicht nachvollziehbaren Gründen auch für die meisten Arzneipflanzenextrakte. Für folgende Indikationen existieren jedoch schon qualitativ gute Präventionsstudien: (Alzheimer-) Demenz (Ginkgo biloba), Erkältungskrankheit (Echinacea spec.) und - mit Einschränkung - koronare Herzkrankheit (Allium sativum).

Summary

Preventive phytotherapy options

Prevention of common diseases is increasingly becoming the focus of attention and public interest. Prevention measures should be feasible and preferably without side effects. This applies to phytotherapy, among others, which therefore could provide appropriate tools for prevention. However, studies on prevention are very time-consuming, expensive and error-prone. As a result, high quality studies are rare; this is true and comprehensible also for prevention studies on herbal medicinal drugs. Nevertheless studies were published with the following indications: Alzheimer/dementia (Ginkgo biloba), common cold (Echinacea spec.) and, with some restriction, coronary heart disease (Allium sativum).

• Literatur

• 1 http://flexikon.doccheck.com/de/Prävention
• 2 Bundesgesetzblatt. Jahrgang 2015; Teil I Nr. 31. 678-684
• 3 Afaq F, Mukhtar H. Botanical antioxidants in the prevention of photocarcinogenesis and photoaging. Exp Dermatol 2006; 15: 678-684
• 4 Bellik Y, Hammoudi SM, Abdellah F et al. Phytochemicals to prevent inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2012; 6: 147-158
• 5 Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol 2012; 13: 218-228
• 6 Pasinetti GM, Wang J, Ho L et al. Roles of resveratrol and other grape-derived polyphenols in Alzheimer‘s disease prevention and treatment. Biochim Biophys Acta 2015; 1852: 1202-1208
• 7 Prakash D, Gupta C. Glucosinolates: the phytochemicals of nutraceutical importance. J Complement Integr Med 2012; 9: 1-3
• 8 Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst Rev 2013; 1: CD001775
• 9 Vellas B, Coley N, Ousset PJ et al. GuidAge Study Group. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012; 11: 851-859
• 10 Melchart D, Walther E, Linde K et al. Echinacea root extracts for the prevention of upper respiratory tract infections - a double-blind, placebocontrolled randomized trial. Arch Family Med 1998; 7: 541-545
• 11 Karsch-Völk M, Barrett B, Linde K. Echinacea for preventing and treating the common cold. J Am Med Assoc 2015; 313: 618-619
• 12 Karsch-Völk M, Barrett B, Kiefer D et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2014; 2: CD000530
• 13 Chiang EP, Chiu SC, Pai MH et al. Organosulfur garlic compounds induce neovasculogenesis in human endothelial progenitor cells through a modulation of microRNA 221 and the PI3-K/Akt signaling pathways. J Agric Food Chem 2013; 61: 4839-4922
• 14 Liu W, Zhang Y, Yu CM et al. Current understanding of coronary artery calcification. J Geriatr Cardiol 2015; 12: 668-675
• 15 Zeb I, Ahmadi N, Nasir K et al. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. J Cardiovasc Dis Res 2012; 3: 185-190
• 16 Matsumoto S, Nakanishi R, Li D et al. Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with metabolic syndrome in a prospective randomized double-blind study. J Nutr 2016; 146-427